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Proteins Needed for Vesicle Budding from the Golgi Complex Are also
Required for the Docking Step of Homotypic Vacuole Fusion
Albert Price, William Wickner, and Christian Ungermann
Department of Biochemistry, Dartmouth Medical School, Hanover, New Hampshire 03755-3844

Abstract. Vam2p/Vps41p is known to be required for
transport vesicles with vacuolar cargo to bud from the
Golgi. Like other VAM-encoded proteins, which are
needed for homotypic vacuole fusion, we now report
that Vam2p and its associated protein Vam6p/Vps39p
are needed on each vacuole partner for homotypic fusion. In vitro vacuole fusion occurs in successive steps
of priming, docking, and membrane fusion. While priming does not require Vam2p or Vam6p, the functions of
these two proteins cannot be fulfilled until priming has

occurred, and each is required for the docking reaction
which culminates in trans-SNARE pairing. Consistent
with their dual function in Golgi vesicle budding and
homotypic fusion of vacuoles, approximately half of the
Vam2p and Vam6p of the cell are recovered from cell
lysates with purified vacuoles.
Key words: Vps41/Vam2p • Vps39/Vam6p • priming •
NSF/Sec18p • ␣SNAP-Sec17p

Introduction
The fusion of cellular membranes during secretion, endocytosis, and organelle inheritance is essential for cellular compartmentation. Highly conserved proteins are involved in fusion events throughout the cell and across
species. These include soluble NSF attachment protein
receptors (SNAREs),1 the ATP-driven chaperone NSF/
Sec18p and its partner proteins ␣SNAP/Sec17p, and a large
family of Rab GTPases. The pairing in trans of cognate
v- (vesicle) and t- (target membrane) SNAREs is a central
event in docking membranes before fusion (Rothman,
1994; Hay and Scheller, 1997). This pairing is regulated
by the prior priming action of NSF/Sec18p and SNAP/
Sec17p, which prepares the SNAREs for docking, and by
Rab GTPases (Mayer and Wickner, 1997; Novick and Zerial, 1997). The relationship of the structurally diverse Rab
effectors and tethering factors (Pfeffer, 1996; TerBush et
al., 1996; Cao et al., 1998; McBride et al., 1999) to docking
is currently studied for several trafficking reactions.
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Abbreviations used in this paper: SNARE, soluble NSF attachment
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We have studied the homotypic fusion of yeast vacuoles.
It occurs in the ordered stages of priming, docking, and bilayer fusion. During priming, individual vacuoles are prepared for interaction with other vacuoles. The starting vacuoles contain a cis complex of SNAREs bound together
on the same vacuole. This cis-SNARE complex includes
a t-SNARE (Vam3p), v-SNAREs (Nyv1p, Vti1p, and
Ykt6p), an s-SNARE (Vam7p, which is a homologue of
the synaptic SNAP-23/25 protein), an ␣-SNAP (Sec17p;
Haas et al., 1995; Haas and Wickner, 1996; Nichols et
al., 1997; Ungermann and Wickner, 1998; Ungermann et
al., 1999a), as well as a novel chaperone (LMA1; Barlowe,
1997; Xu et al., 1997, 1998). In priming, the action of
Sec17p, Sec18p, and LMA1 disassembles the cis-SNARE
complex. Sec17p is released, the t-SNARE is activated,
and LMA1 stabilizes the primed t-SNARE (Mayer et al.,
1996; Ungermann et al., 1998; Xu et al., 1998). The primed
vacuoles come into contact during docking. The initial
tethering stage of docking is reversible and independent of
SNAREs, but requires Ypt7p, a small GTP-binding protein of the Rab family (Ungermann et al., 1998). The interaction between vacuoles becomes irreversible through the
association of SNARE proteins from apposed vacuoles,
forming a trans-SNARE complex. trans-SNARE pairing
triggers the release of lumenal calcium to interact with
calmodulin and mediate downstream events that lead to
fusion (Peters and Mayer, 1998). These events include the
release of LMA1 from the t-SNARE, which is regulated
by a phosphatase-kinase pair (Xu et al., 1998).
Mutations in the genes encoding many of the above pro-
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teins, which were shown biochemically to catalyze each
stage of the fusion reaction, cause severe vacuole fragmentation in the intact cell, presumably reflecting a failure of
vacuole fusion. Type II vacuole morphology (vam) mutants were obtained in a nonselective screen for just such a
highly fragmented vacuole morphology. Since Vam3p,
Vam4/Ypt7p, and Vam7p are each involved in the reaction, we examined whether Vam2p and Vam6p are also required. These proteins are required for normal vacuole
morphology (Wada et al., 1992; Nakamura et al., 1997;
Zheng et al., 1998), for protein sorting to the vacuole
(Raymond et al., 1992; Cowles et al., 1997; Rehling et al.,
1999) and for cytosol-to-vacuole protein targeting (Harding et al., 1995). Though Vam2p and Vam6p are reported
to be localized to the vacuole (Wada et al., 1992) and to be
associated in a large complex (Nakamura et al., 1997),
Vps41p/Vam2p also fulfills a specific role in transport vesicle budding from the Golgi (Rehling et al., 1999,), where
it interacts with the AP3 coat. We now report that approximately half of the Vam2p and Vam6p of the cell copurifies with vacuoles, and that it is required for the docking
stage of homotypic vacuole fusion and for the formation of
stable trans-SNARE pairs.

Materials and Methods
Yeast Strains and Genetic Manipulations
Saccharomyces cerevisiae strains BJ3505 (MATa pep4::HIS3 prb1-⌬1.6R
HIS3 lys2-208 trp1-D101 ura3-52 gal2 can) and DKY 6281 (MATa leu2-3
leu2-112 ura3-52 his3-D200 trp1-D901 lys2-801 suc2-D9 pho8::TRP1)
were used. The VAM2 and VAM6 genes were disrupted in S. cerevisiae
BJ3505 by recombination with PCR-generated cassettes containing 5⬘ and
3⬘ homologous regions of either VAM2 or VAM6 and the URA3 gene of
S. cerevisiae. The PCR primers contained 40 bases of identity to the regions flanking the open reading frame (VAM6 5⬘ primer sequence: 5⬘
CAG CAA AAA CCC TTC AAA ATA TCA ATT TAT ACC AAA
AAT TAA GAT TCC GGT TTC TTT GAA AT 3⬘; VAM6 3⬘ primer sequence 5⬘ ATA AGA AAT ACT AAC AAC AAT AAC AGC AGC
TGT TAA GGG ATC TCT AAT TTG TGA GTT TAG TAT AC 3⬘;
VAM2 5⬘ primer sequence: 5⬘ AAA GCA TTT TAA CGA AGA GTA
TAT ACC TAC TAT TAG ACA TTA GAT TCC GGT TTC TTT GAA
AT 3⬘; and VAM2 3⬘ primer sequence 5⬘ TGA AGT GTA CAC TTG
CCT TGT GTA TTA AAT GAT GAT TCG ATA TCT AAT TTG TGA
GTT TAG TAT AC 3⬘). Transformants were screened for the expected
deletion by PCR using primers that anneal to the promoter region of the
VAM2 or VAM6 genes (VAM2 primer sequence 5⬘ GGG CTA TTG
AGA CTGV TTG 3⬘; and VAM6 primer sequence 5⬘ TAG GTT TAC
GGC TGT TCA A 3⬘), the coding region of the URA3 gene (5⬘CCC AAT
GCG TCT CCC TT 3⬘), and isolated genomic DNA from the selected
clones by PCR (Ausubel et al., 1995). Deletions were confirmed by SDSPAGE immunoblotting (Harlow and Lane, 1988) with antibodies to
Vam2p and Vam6p.

(Qiagen). Antibodies were affinity-purified using columns of recombinant
Vam2 or Vam6 proteins coupled to Affi-Gel (Bio-Rad Laboratories) and
dialyzed into PS buffer (20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol).
Fab fragments of anti-Vam2 were prepared by papain digestion (ImmunoPure Fab kit; Pierce Chemical Co.), affinity-purified as described
above, and dialyzed into PS buffer. Antibodies against Ypt7p (Haas et al.,
1995), Sec18p (Haas and Wickner, 1996), and Vam3p (Nichols et al., 1997)
were purified as described previously and dialyzed into PS buffer.

Vacuole Fusion Assay
Vacuole isolation and fusion assays were performed as described previously (Haas, 1995).

Results
Vam2p and Vam6p Are Required on both Partner
Vacuoles for Fusion
Vam2/Vps41p and Vam6/Vps39p, fused to green fluorescent protein, are localized to the vacuole in vivo (Wada et
al., 1992) and, yet, Vam2p is also found associated with
AP-3 coat adapter subunits on the Golgi and is required
there for vesicle budding (Rehling et al., 1999). To determine whether the proportion of Vam2p and Vam6p recovered with the vacuoles was consistent with vacuolar and/or
nonvacuolar localizations, we purified vacuoles from cell
lysates and compared the recovery of Vam2p and Vam6p
with that of Pho8p, an established vacuolar marker protein. We find that 45% of the Vam2p and 54% of the
Vam6p are recovered in our purified vacuoles, after correction for the loss of 23% of the vacuole marker Pho8p
during isolation (Fig. 1). The presence of Vam2p and
Vam6p in this fraction is not due to contaminating Golgi,
as ⬍5% of the late Golgi marker Kex2p is recovered with
the vacuoles (Fig. 1). Thus, half of the Vam2p and Vam6p
is localized to the vacuole while the rest is elsewhere in the
cell, in accordance with both Wada et al. (1992) and Rehling et al. (1999).
To investigate the functions of Vam2p and Vam6p, we
have employed an in vitro assay of vacuole fusion. Vacuoles are purified from two S. cerevisiae strains bearing deletions in either the PEP4 gene or the PHO8 gene. Fusion
of these vacuoles exposes pro-alkaline phosphatase from
one vacuole population to its activating protease from the

Figure 1. Vam2p and Vam6p are
associated with purified vacuoles. A
BJ3505 wild-type culture was processed for vacuole purification
(Haas, 1995). An aliquot of spheroplasted yeast cells was lysed by boiling in SDS-PAGE loading buffer,
and the remaining spheroplasts
were carried through the vacuole
purification. Equivalent proportions of spheroplasts and purified
vacuoles (0.1% of the total preparation) were analyzed by SDS-PAGE
and immunoblotting with antisera
against the indicated proteins. Recovery of proteins in the purified
vacuoles was determined by scanning densitometry (see text).

Biochemical Reagents
All inhibitors and antibodies were dissolved in or dialyzed into PS buffer
(20 mM Pipes-KOH, pH 6.8, 200 mM sorbitol) unless stated otherwise.

Antibody Production and Purification
Antibodies against the Vam2 and Vam6 proteins were raised in rabbits using recombinant His6-tagged proteins purified from Escherichia coli. The
coding sequences for S. cerevisiae VAM2 and VAM6 were PCR amplified
(VAM2 5⬘ primer: 5⬘ AGT ACC GGA TCC ATG ACT ACA GAT
AAT CAT 3⬘; VAM2 3⬘ primer: 5⬘ AGT GTT GGT ACC TTA TAA
ACA CCA TTT AA 3⬘; VAM6 5⬘ primer: 5⬘ AGT GTT GGT ACC TTA
CTT ATT ATT TAG GTC 3⬘; and VAM6 3⬘ primer: 5⬘ AGT ACC GGA
TCC ATG TTA AGA GCT CAA AAG 3⬘) and cloned into pQE30
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Figure 3. Active Vam2p and Vam6p are required on both vacuole fusion partners. BJ3505 or DKY6281 vacuoles were mixed
with buffer or antibodies against Vam2p or Vam6p. After 10 min,
at 0⬚C, vacuoles were diluted 20-fold with PS buffer and reisolated to remove unbound antibody. Vacuole fusion partners were
combined in standard fusion reactions supplemented with cytosol
(30 g/ml).

Figure 2. Vacuole fusion requires Vam2p and Vam6p. (A) Protein composition of vacuoles. Vacuolar protein (15 g) from
wild-type, vam2⌬, and vam6⌬ strains was analyzed by SDSPAGE and immunoblotting with antisera to the indicated vacuolar proteins. (B) In vitro fusion of vacuoles from wild-type,
vam2⌬, and vam6⌬ strains. Standard vacuole fusion reactions
(see Materials and Methods) were performed with BJ3505 wildtype, vam2⌬, or vam6⌬ vacuoles combined with wild-type
DKY6281 vacuoles.

other, resulting in the production of enzymatically active
alkaline phosphatase, which is assayed spectrophotometrically. The VAM2 and VAM6 genes were deleted in one of
our vacuole fusion tester strains, BJ3505. Although mutations in VAM2 and VAM6 affect the rate of trafficking of
proteins to the vacuole in vivo (Nakamura et al., 1997;
Radisky et al., 1997), the steady state levels of the vacuolar
marker proteins Pho8p, CPY, and Vma1p are unaffected
in our purified vacuole preparations (Fig. 2 A). Thus,
whereas these vacuoles are smaller than wild type (Nakamura et al., 1997) and are often recovered with somewhat
lower yield, they contain the normal complement of vacuolar proteins. However, when normal amounts (assayed
by Bradford protein determination) of vacuoles derived
from BJ3505 vam2⌬ or vam6⌬ strains are combined with
wild-type DKY6281 partner vacuoles in standard fusion
reactions, the resulting fusion is ⬍10% of that seen with
wild-type vacuoles (Fig. 2 B). Since these vacuoles have
normal levels of vacuole marker proteins (Fig. 2 A), except for Vam2p or Vam6p, and since small vacuole size
alone is not a hindrance to fusion (see Fig. 4 b in Nichols et
al., 1997), the simplest inference is that Vam2p and Vam6p
are directly involved in fusion.
Affinity-purified antibodies to Vam2p or Vam6, or their
respective Fab fragments, efficiently inhibited in vitro vacuole fusion, whereas preimmune IgG did not (data not
shown). Since fusion is compromised when VAM2 or
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VAM6 are deleted on only one vacuole fusion partner
(Fig. 2 B), we tested whether antibodies to Vam2p or
Vam6p inhibit fusion if added to only one partner vacuole.
Wild-type DKY6281 vacuoles were incubated on ice with
antibody to either Vam2p or Vam6p and reisolated to remove unbound antibody. These vacuoles were combined
with untreated or antibody-treated BJ3505 vacuole partners in standard fusion reactions. Treatment of only one
vacuole type with antibody against Vam2p or Vam6p inhibited fusion (Fig. 3, lanes 3 and 4) to the same extent as
seen when both fusion partners were treated (Fig. 3, lanes
5 and 6). Thus, homotypic vacuole fusion requires Vam2p
and Vam6p on both fusion partners.

Vam2p and Vam6p Are Required for Docking
Sec18-primed Vacuoles
Previous studies of vacuole fusion in vitro have defined
three distinct reaction stages. First, priming requires the
action of Sec17p and Sec18p (Mayer et al., 1996). Second,
docking requires primed vacuoles, v- and t-SNAREs, and
Ypt7p (Mayer and Wickner, 1997; Ungermann and Wickner, 1998). Third, fusion no longer requires trans-SNARE
pairs (Ungermann et al., 1998) but needs calmodulin (Peters and Mayer, 1998) and protein phosphatase 1 (Peters
et al., 1999). To determine the stages where Vam2p and
Vam6p act, aliquots were removed from vacuole fusion reactions at various times and mixed with buffer or inhibitors, or placed on ice, and the incubation was continued
until all samples had been incubated for 90 min (Fig. 4). In
contrast to the inhibition by anti-Sec18p (closed squares),
which is only seen at early reaction times, resistance to
anti-Vam2p (crosses) and anti-Vam6p (closed triangles) is
achieved with intermediate kinetics that correspond to the
docking stage inhibitors Gdi1p (open triangles) or the antibody to the t-SNARE Vam3p (diamonds; Mayer and
Wickner, 1997; Ungermann et al., 1998). Resistance to
anti-Vam2p and anti-Vam6p is achieved before fusion itself (open squares), suggesting that these factors are not
needed for the fusion stage of the reaction. These proteins
are also not involved in priming, since antibodies to
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Figure 4. Kinetics of acquisition of resistance to Gdi1p and antibodies to Vam3p, Vam2p, and Vam6p. Aliquots (30 l) were removed from 10⫻ scale fusion reactions at the indicated times and
added to control buffer on ice, buffer at 27⬚C, Gdi1p (64 g/ml),
or antibodies against Sec18p, Vam3p, Vam2p, or Vam6p at 27⬚C.
Fusion reactions were incubated for a total of 90 min at 27⬚C before being assayed for alkaline phosphatase activity.

Vam2p and Vam6p have no effect on Sec17p release from
the vacuoles (data not shown), indicating that these components are not involved in priming (Mayer et al., 1996).
To further investigate the role of Vam2p and Vam6p in
docking, fusion reactions without inhibitors were started
with the partner vacuoles in separate tubes. At various
times, aliquots of each preincubated vacuole population
were combined with inhibitors and with each other, and
the reaction was continued for 70 min (Fig. 5). Resistance

to anti-Sec18p (closed squares) is achieved early, confirming that the priming subreaction can occur when vacuoles
are separated (Mayer et al., 1996). However, as with an
inhibitor of Ypt7p (open triangles), resistance to antiVam2p (crosses) and anti-Vam6p (closed triangles) is
never achieved when the vacuole partners are in separate
tubes. Therefore, the action of Vam2p and Vam6p requires contact between vacuole fusion partners and indicates a role in docking.
Homotypic vacuole fusion requires the early action of
Sec18p to prime the vacuoles for subsequent docking
(Mayer et al., 1996; Mayer and Wickner, 1997). To determine whether priming is a prerequisite for the action of
Vam2p and Vam6p, a two-stage experiment was performed in which the activity of Sec18p was inhibited by
anti-Sec18p antibody in the first incubation. After 30 min,
a time which otherwise suffices for the acquisition of resistance to Gdi1p or to antibodies to Vam3p, Vam2p, or
Vam6p (Fig. 4), Sec18p activity was restored by the addition of Sec18 protein, and the reaction was continued in
the presence or absence of inhibitors. Fusion is restored by
the addition of Sec18p in the second incubation (Fig. 6,
lane 2). However, as with the docking inhibitors Gdi1p
and anti-Vam3p, the reaction remains fully sensitive to
anti-Vam2p and anti-Vam6p (Fig. 6, lanes 3–6). Thus,
Sec18p must act before Vam2p and Vam6p can fulfill their
functions.
We have previously reported that docking can be divided into the stages of Ypt7p-dependent tethering, followed by trans-SNARE pairing. These stages are distinguished by the addition of an excess of Sec18p to vacuole
fusion reactions, which allows Ypt7p to complete its function while preventing stable trans-SNARE pairing (Ungermann et al., 1998). To examine the role of Vam2/6p in
docking, vacuoles were incubated under standard fusion
conditions for 20 min, but with an excess of Sec18p, and an

Figure 5. Completion of Vam2p and Vam6p function requires
vacuole docking. 10⫻ scale reactions with vacuoles from either
BJ3505 or DKY6281 were incubated at 27⬚C in the presence of
ATP. At the indicated times, 15-l aliquots were removed from
each reaction and combined in the presence of control buffer on
ice, control buffer at 27⬚C, Gdi1p, antibody to Vam3p, Vam2p, or
Vam6p at 27⬚C, incubated for 70 min at 27⬚C, and analyzed for
alkaline phosphatase activity.

Figure 6. The action of Sec18p must precede that of Vam2p and
Vam6p. A 10⫻ scale fusion reaction with affinity-purified antibody against Sec18p was incubated at 27⬚C for 30 min. The vacuoles were reisolated and resuspended in the original volume of
reaction buffer containing 25 g/ml Sec18p and divided into 30l aliquots. Where indicated, Gdi1p or antibodies against
Vam3p, Vam2p, or Vam6p were added. The incubations were
continued at 27⬚C for 90 min and analyzed for alkaline phosphatase activity. The background activity of 0.22 U (a sample
transferred to ice after the first 30-min incubation) was subtracted.
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Figure 8. Vam2/6p is required for trans-SNARE pairing. The
formation of trans-SNARE pairs between vacuoles was assayed
as described in Ungermann et al. (1998). Vacuoles from strains
BJ3505nyv1⌬ and DKY6281vam3⌬ (100 g each) were incubated together at 27⬚C (lanes 2–4) or on ice (lane 1) with cytosol
and ATP for 30 min. Reactions were supplemented with control
buffer (lanes 1 and 2), affinity-purified anti-Vam2p IgG (lane 3),
or affinity-purified anti-Vam2p Fab fragment (lane 4). Protein
complexes were analyzed by coimmunoprecipitation with protein
A–immobilized antibodies to Vam3p, SDS-PAGE, and immunoblotting with antibodies to Vam3p and Nyv1p.

Figure 7. Vam2/6p continues to function after Ypt7p. Standard
fusion reactions were supplemented with cytosol and excess
Sec18p (3.8 g) to prevent SNARE pairing and incubated on ice
(lane 1) or at 27⬚C for 20 min. After 20 min, one reaction was
placed on ice (lane 2), the others received inhibitors or antibodies
and were placed on ice for 3 min. Reactions were diluted with 500
l PS buffer. Vacuoles were sedimented (for 5 min, 10,000 g, at
4⬚C) and resuspended in the original volume of reaction buffer
(without cytosol and Sec18p). The indicated inhibitors were
added and the reaction continued for 70 min at 27⬚C. Fusion activity was measured and background activity (0.25 U) was subtracted.

Discussion

aliquot was assayed for the fusion that had occurred (Fig.
7, lane 2). Other portions were sedimented to remove the
excess Sec18p and resuspended in buffer alone (lane 5) or
with other fusion inhibitors (Fig. 7, lanes 6–8) for a second,
70-min incubation. Whereas the reaction had become resistant to Gdi1p (lane 6), it was still fully sensitive to antibody to Vam3p (lane 7) or to Vam2p (lane 8), suggesting
that Vam2/6p may complete its function after Ypt7p but
before SNAREs pair in trans.
To directly assay whether Vam2/6p is needed, after
priming and during docking, for the formation of transSNARE pairs between the t-SNARE Vam3p on one vacuole with the v-SNARE Nyv1p on another vacuole, we incubated vacuoles from a vam3⌬ strain with vacuoles from
a nyv1⌬ strain, exploiting the fact that neither initial vacuole population can have Vam3p:Nyv1p complexes (Ungermann et al., 1998b). As previously shown (see Fig. 5 C in
Ungermann et al., 1998b), the SNARE complexes that
form at 27⬚C, and are assayed by the coprecipitation of
Nyv1p by antibody to Vam3p, are truly in trans (i.e., between apposed vacuoles), as their formation is not blocked
by Microcystin-LR, which is a potent inhibitor of fusion.
We find that the formation of trans-SNARE pairs in such
an assay (Fig. 8, lane 2) is blocked by antibody to Vam2p
(lane 3) or by its monovalent Fab fragment (lane 4), confirming that Vam2/6p is required for the completion of
docking.

Vam2p and Vam6p are components of a multifunctional
complex that is required both for protein trafficking to the
vacuole (Raymond et al., 1992; Harding et al., 1995;
Cowles et al., 1997; Nakamura et al., 1997) as well as for
homotypic vacuole–vacuole fusion. Surprisingly, recent
findings have suggested a novel function for Vam2/
Vps41p. Emr and colleagues (Rehling et al., 1999) have
shown that this protein is required for the formation of vesicular transport intermediates of the vacuole ALP (alkaline phosphatase) pathway at the trans-Golgi. They
further demonstrated that Vam2/Vps41p interacts with
components of a clathrin coat adapter complex by binding
directly to the AP-3 subunit Apl5. On the other hand, we
find that Vam2 and its partner protein Vam6 (Nakamura
et al., 1997; Price et al., accompanying manuscript) are required for the docking stage of homotypic vacuole fusion. The fragmented vacuole phenotype seen in vam2
and vam6 mutants is identical to that seen in mutants of
the small G protein Vam4/Ypt7p and the vacuolar
t-SNARE (Wada et al., 1992; Haas et al., 1995; Nakamura et al., 1997; Nichols et al., 1997). Each of these proteins has been shown biochemically to act at the docking
stage of the homotypic vacuole fusion reaction. Vam2p
and Vam6p localize to the vacuole in vivo (Nakamura et
al., 1997); additional localization to the Golgi or Golgiderived vesicles might have been difficult to visualize.
Vam2p and Vam6p presumably use different receptors at
the Golgi and vacuole, which is consistent with the findings that vacuolar Ypt7p is needed for optimal steady state
association of Vam2p and Vam6p at the vacuole (Price et
al., 2000 [this issue]) and, yet, normal budding of trafficking vesicles from the Golgi (Rehling et al., 1999) may not
require Ypt7p. We have shown that approximately half of
the Vam2 and Vam6 copurify with vacuoles (when compared with the vacuole marker protein Pho8p), whereas
Kex2p, a trans-Golgi marker protein, does not (Fig. 1).
In the accompanying manuscript (Price et al., 2000 [this issue]), we demonstrate that both Vam2p and Vam6p are physically and functionally associated with factors specifically required for homotypic vacuole fusion. Except for the study
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of Springer and Schekman (1998), which showed that
SNARE proteins nucleate COPII budding from the yeast
ER, there is little precedent for such an unusual dual function in both vesicle budding and membrane docking. This
raises the fascinating possibility that Vam2/6p may couple
these processes in vivo. Further work will be required to
test this idea.
Since many of the same proteins are needed for heterotypic trafficking to the vacuole and for homotypic vacuole fusion, the recovery of organelles with vacuole density from lysates of vam2⌬, vam6⌬, vam3⌬, and ypt7⌬
strains, and the demonstration that these organelles contain vacuole marker proteins at approximately normal
specific activities, raises a question of their identity and origins. They may be small, but rather normal, vacuoles that
have obtained most of their proteins by slow, or even bypass, pathways and are small because of defective homotypic fusion. Alternatively, they may represent an earlier
organelle on the Golgi to vacuole pathways that has expanded because of accumulated vacuole proteins until it
acquires certain vacuole characteristics such as density.
Further studies are needed to resolve this yet, in either
case, assay of the capacity of this organelle to fuse with
vacuoles from wild-type cells provides one measure of the
role of the missing protein in fusion pathways. Other complementary assays are inhibition of the homotypic fusion
of wild-type vacuoles by the relevant antibody and, as detailed for Vam2p and Vam6p in the accompanying manuscript (Price et al., 2000), direct demonstration of physical
and functional associations with other catalysts of vacuole
fusion such as Ypt7p and SNAREs.
How general is the yeast vacuole and the role of Vam2p
and Vam6p in its fusion as a model for priming and docking in other vesicle trafficking pathways? Yeast vacuoles
require priming before docking (Mayer and Wickner,
1997) and, in this regard, might be thought to differ, at
least superficially, from other trafficking reactions. For example, the priming of SNAREs by NSF and SNAP is not
needed for docking at the neural synapse in Drosophila
(Littleton et al., 1998) and Cao et al. (1998) have shown
that the docking of ER-derived vesicles at the Golgi requires Uso1p but not the priming of SNAREs by Sec18p.
However, we suggest that there is a fundamental unity in
these three systems. Vacuole tethering is mediated by
Ypt7p, but it is not mediated by the pairing of SNAREs in
trans (Ungermann et al., 1998). Vacuoles from a vam3⌬
strain, in which the SNAREs are not associated in cis with
each other (Ungermann and Wickner, 1998), can also
tether without priming (Ungermann et al., 1998), as in
the studies of Cao et al. (1998). Furthermore, since synaptic transmission is sensitive to some proteolytic toxins that
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The docking process is now known to require an unexpected variety of factors. These include t- and v-SNAREs
on apposed vacuoles (Nichols et al., 1997), the Rab-like
Ypt7p on both vacuoles (Haas et al., 1995), vacuolar phosphatidylinositol 4,5-bisphosphate (Mayer et al., 2000), vacuole acidification (Ungermann et al., 1999b), and now
Vam2p and Vam6p. The relationships between these factors are not clear. However, in an accompanying paper, we
show that a complex that contains Vam2p and Vam6p
functions as an effector complex for Ypt7p, linking membrane priming to trans-SNARE pairing. Our finding (Fig.
7) that Vam2p is still needed even after Ypt7p has completed its function suggests that Vam2p might function between Ypt7p-mediated tethering and trans-SNARE pairing. This result is consistent with the finding that Vam2p is
needed for trans-SNARE pairing (Fig. 8), but further
studies will be needed to test this hypothesis.
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